Sunday, June 21, 2020 1:38:16 PM
All long shareholders should be critical of PRED's performance. I also look at my accounts and cringe.....
But I believe PRED will turn the quarter very soon. (Pun intended here, In my opinion, the June Quarter will not be a good one......unless by some miracle, they sold Dablood tests.........maximum pain on Covid, Max pain with Stems cells.) But this should be the bottom.
Fiscal Q1 (Sept Quarter) should bring all long shareholders some well needed relief. PRED for the first time will have more than one revenue stream, up till now, it's been stem cells. But now we can include a 2nd (Dablood tests), and possibly a 3rd revenue stream.
- Commercial availability of Dablood tests.
- Improvement in Stem cell business.
- Introduction of new services from their CLIA lab. PRED has equipment capable of generating some revenue, why not use it. (They paid a lot of money for the Lab business - earn some of that shareholder money back.)
PRED - don't let us long shareholders down - you owe us some hard work and forward progress. Buckle up and get to work.
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM